Alio Raises $20M in Series B Financing
Summary
SAN FRANCISCO, June 30, 2021 /PRNewswire/ -- Alio Medical, a wearable technology company enabling greater insights through clinical grade real-time data, announced the close of a Series B financing round totaling $20 million. "This funding provides us with the resources to advance key clinical programs and partnerships assessing remote monitoring benefits for chronic kidney disease and dialysis patients, and further enhance our transformative technology to strategically scale our platform," said David Kuraguntla, Alios co-founder and CEO. "The approach to chronic kidney disease and dialysis has not changed all that much in decades, and it remains a huge burden to the healthcare system," said Thomas Krebs. "Alios clinical-grade sensors and remote monitoring platforms offer the ability to decrease the cost and increase the availability of real-time insights on chronic kidney disease and a number of other conditions. Our primary monitoring platform, powered by the SmartPatch, seamlessly connects other clinical grade sensors through proprietary technology.